PLX icon

Protalix BioTherapeutics
PLX

Overview Fund Activity

33 hedge funds and large institutions have $21.2M invested in Protalix BioTherapeutics in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 2 closing their positions.

Holders
33
Holders Change
+2
Holders Change %
+6.45%
% of All Funds
0.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
10
Closed
2
Calls
–
Puts
$27K
Net Calls
-$27K
Net Calls Change
+$17K

Top Buyers

1
BC
1
Broadfin Capital
New York
$2.85M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$46K
3
HSBC Holdings
3
HSBC Holdings
United Kingdom
$13K
4
FANJ
4
Financial Architects (New Jersey)
New Jersey
$8K
5
Citadel Advisors
5
Citadel Advisors
Florida
$22K

Top Sellers

1
State of Wisconsin Investment Board
1
State of Wisconsin Investment Board
Wisconsin
$0
2
Morgan Stanley
2
Morgan Stanley
New York
$1K
3
SIM
3
Spark Investment Management
New York
$92K
4
Jane Street
4
Jane Street
New York
$33K
5
ARTA
5
A.R.T. Advisors
New York
$18K
Name Holding Trade Value Shares
Change 		Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
$1K -$104K -11,484 -99%
Wells Fargo
27
Wells Fargo
California
$1K – – –
State of Wisconsin Investment Board
28
State of Wisconsin Investment Board
Wisconsin
– -$265K -25,950 Closed
TC
29
TFS Capital
Pennsylvania
– -$32K -3,123 Closed
1
2